Biospring Partners is a venture capital fund that invests in Series A companies in the biotech, health tech, and pharma sectors. They offer check sizes between $500,000 and $10 million, supporting B2B services, tools, and enterprise software companies using their deep life sciences and technology expertise. One of their investments is Abzena. Follow them on Twitter @biosprings.
